Koxitor 120 is a high-strength selective COX-2 inhibitor formulated to support the short-term management of acute inflammatory pain conditions.
The formulation assists healthcare professionals in addressing intense inflammatory responses associated with musculoskeletal and joint disorders, helping maintain patient comfort under physician-directed therapy.
Category : Tablets & Capsules
Get a QuoteKoxitor 120 contains Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor developed for inflammatory pain management.
By selectively inhibiting the COX-2 enzyme responsible for prostaglandin synthesis, Etoricoxib helps reduce inflammation and associated pain signaling. This targeted mechanism supports effective inflammatory control while maintaining gastrointestinal tolerability compared to non-selective NSAIDs.
The 120 mg strength is generally considered for acute or more severe inflammatory presentations, as determined by clinical evaluation.
Composition
Etoricoxib 120 mg Tablets
Intended Use
Koxitor 120 Tablets are intended for the management of:
Treatment duration and dosage should be determined by a registered healthcare professional based on individual patient assessment.
| Property | Details |
|---|---|
| Dosage Form: | Tablet |
| Therapeutic Category: | Selective COX-2 Inhibitor / NSAID |
| Pack Size: | 10 × 10 Alu-Alu |
| Route of Administration: | Oral |
| Brand: | Servochem |
